Evidence map›Paper›PMID 19235262›Full record

ArticleMagnetic resonance in medicine2009

High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI.

M M Pike, C N Stoops, C P Langford, N S Akella, L B Nabors, G Y Gillespie

Open access · bronzeAbstract read
In one paragraph

Article in Magnetic resonance in medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Whole-brain perfusion mapping in mice by dynamic BOLD MRI with transient hypoxia.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Comparison of first pass bolus AIFs extracted from sequentialNuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment · 2014
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

M M PikeDepartment of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA. pikema@ohsu.edu
C N Stoops
C P Langford
N S Akella
L B Nabors
G Y Gillespie
University of Alabama at Birmingham · USAdvanced Imaging Research (United States) · US

Funding

Virus Production CoreP01CA071933 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEICHSELBAUM, RALPH R · 1997 to 2013
$14.5M
Viral and molecular chemotherapy of malignant CNS tumorsP50CA097247 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GILLESPIE, G. YANCEY · 2002 to 2009
$13.5M
Post-transcriptional Regulation Requires Phosphorylation of HuR in GliomaR01CA112397 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NABORS, LOUIS B · 2006 to 2009
$910k
Endpoint Analyses of Anti-Integrin Therapy for GliomasR21CA091560 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NABORS, LOUIS B · 2003 to 2004
$653k
MRI Assessment of Anti-angiogenesis in Mouse GliomasR21CA114279 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI PIKE, MARTIN M · 2008 to 2009
$381k
NCI NIH HHS CA091560NCI NIH HHS CA112397NCI NIH HHS P01 CA071933NCI NIH HHS P50 CA097247NCI NIH HHS R01 CA112397NCI NIH HHS R21 CA091560NCI NIH HHS R21 CA114279
6 · The paper itself

Abstract

The poor prognosis associated with malignant glioma is largely attributable to its invasiveness and robust angiogenesis. Angiogenesis involves host-tumor interaction and requires in vivo evaluation. Despite their versatility, few studies have used mouse glioma models with perfusion MRI approaches, and generally lack longitudinal study design. Using a micro-MRI system (8.5 Tesla), a novel dual bolus-tracking perfusion MRI strategy was implemented. Using the small molecule contrast agent Magnevist, dynamic contrast enhanced MRI was implemented in the intracranial 4C8 mouse glioma model to determine K(trans) and v(e), indices of tumor vascular permeability and cellularity, respectively. Dynamic susceptibility contrast MRI was subsequently implemented to assess both cerebral blood flow and volume, using the macromolecular superparamagnetic iron oxide, Feridex, which circumvented tumor bolus susceptibility curve distortions from first-pass extravasation. The high-resolution parametric maps obtained over 4 weeks, indicated a progression of tumor vascularization, permeability, and decreased cellularity with tumor growth. In conclusion, a comprehensive array of key parameters were reliably quantified in a longitudinal mouse glioma study. The syngeneic 4C8 intracerebral mouse tumor model has excellent characteristics for studies of glioma angiogenesis. This approach provides a useful platform for noninvasive and highly diagnostic longitudinal investigations of anti-angiogenesis strategies in a relevant orthotopic animal model.

Indexed as

Ferric CompoundsAnimalsBlood Flow VelocityBrain NeoplasmsCell Line, TumorContrast MediaFemaleGliomaImage EnhancementMagnetic Resonance ImagingMiceMice, Inbred C57BLMolecular WeightNeovascularization, PathologicPermeabilityContrast MediaFerric Compoundsferric oxide

Identifiers

PMID19235262
PMCPMC3243360
OpenAlexW1974749881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.